Brivanib alaninate inhibited dengue virus proliferation through VEGFR2/AMPK pathway.
Sign Up to like & getrecommendations! Published in 2021 at "Pharmacological research"
DOI: 10.1016/j.phrs.2021.105721
Abstract: Dengue virus (DENV) is the most prevalent arthropod-borne viral disease of humans and has a major impact on global public health. There is no clinically approved drugs for DENV infection. Since intracellular VEGFR2 is increased… read more here.
Keywords: dengue virus; brivanib alaninate; infection; proliferation ... See more keywords